SERPINE1 and liver disorder: Moreover, urokinase plasminogen activator (u-PA) and its receptor are increased but, during the progression of liver disease, plasminogen activator inhibitor 1 (PAI-1) production becomes prominent, even if at a lower rate in respect to those of t-PA.